Dr. Desh Bandhu Gupta Net Worth

Desh Bandhu Gupta is an Indian pharmacist and billionaire who has a net worth of $3.9 billion. He was born in 1938 in Mumbai and is the founder of Lupin Limited, a pharmaceutical company. Gupta has earned his wealth through his successful business venture and is now one of the wealthiest people in India.
Dr. Desh Bandhu Gupta is a member of Richest Billionaires

Age, Biography and Wiki

Birth Day February 8, 1938
Birth Place India
Age 79 YEARS OLD
Died On 2017
Birth Sign Aquarius
Net Worth: $3.9 Billion
Gender: Male

💰 Net worth: $3.9 Billion (2024)

As of 2024, Dr. Desh Bandhu Gupta's net worth is estimated to be a staggering $3.9 billion, making him one of the richest billionaires in India. Dr. Gupta has built his wealth through his successful pharmaceutical career and entrepreneurial ventures. As the founder of Lupin Limited, a leading multinational pharmaceutical company, Dr. Gupta has led the company to great heights, establishing it as a major player in the global healthcare industry. His astute business acumen and relentless pursuit of innovation have propelled Lupin's growth and secured his position as one of India's most influential figures in the business world. With his immense wealth, Dr. Desh Bandhu Gupta continues to leave an indelible mark in the realm of entrepreneurship and contribute to the development of healthcare solutions globally.

A Doctor of Science who also has a Master's degree in Chemistry of Bombay University, Gupta started his career path as an assistant professor at the Birla Institute of Technology and Sciences. Governed by his desire to fight life-threatening diseases led him to launch Lupin in 1968 as a little vitamin company with a really small investment of $120. During the years, Lupin grew into one of the leading producers of anti-tuberculosis drugs and Cephalosporin antibiotics segments worldwide.

Today, the company holds six research centers based in India and Japan, and it is operating in 12 factories with an income of about $1.7 billion annually. Last year, Gupta or, as he is popularly called, DBG handed over the pharmaceutical empire to his children: Vinita, his daughter, and Nilesh, his son, but he remains to serve as Chairman. Moreover, he was honored with the Lifetime Achievement Award for his contributions to the Pharmaceutical Leadership Summit in 2009, and he received the Visionary Leader award at 2011 Earnest and Young Entrepreneur of the Year Awards gala.